Table: begin end state 1 11 cytoplasmic 12 33 transmembrane 34 40 non-cytoplasmic 41 65 transmembrane 66 95 cytoplasmic 96 118 transmembrane 119 153 non-cytoplasmic 154 173 transmembrane 174 183 cytoplasmic 184 204 transmembrane 205 224 non-cytoplasmic 225 247 transmembrane 248 257 cytoplasmic 258 284 transmembrane 285 304 non-cytoplasmic 305 328 transmembrane 329 348 cytoplasmic 349 371 transmembrane 372 406 non-cytoplasmic 407 426 transmembrane 427 439 cytoplasmic 440 465 transmembrane 466 467 non-cytoplasmic
Input: >AO353_05685 FitnessBrowser__pseudo3_N2E3:AO353_05685 MSSDKVSVHGSWASRWVFILAATGSAVGLGSIWKFPYMVGVYGGGAFVLVFLACIALIGV PVMLAETLIGRRARQSPANALKVLALEAGHSAKWSWGAFAGMITALLILSFYSVVGGWSL DYIIDMGRGDFQGVTADQVGAYFGGVIADPWRLTLWHTLFMLLSAFVIARGVVAGLERSL RIMMPLLFVMLVILLGYSLTTGHFMEGVHFMFDFNPDKLLDGLLPAMGHAFFSLSVGVGS IMIYGAYMPKHSSISGTIVGVALLDTFVSLLAGLALFPIVFAAGLNPSEGPGLMFVSLPF AFGNVAFGQLMGVVFFVLVAIAAWSSAISLLEPMVAYLVERTNIRRGWVTFWLAFSCWFV GLGTVFSFNIWKQAKFFVNDGGAFHLYQWGAQNGLDFFGVIDFFTSRIMLPLGGLCFVVF AGWVMGREAVRDELSMRSPALFALTLFLMRYVAPIGILVVFAAQLWK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server